Jonathan Hsu, PA
Physician Assistant · Lewistown, PANPI 1649726514
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,223 of the $23,568 with a category attached, or 73.1%. Abbott accounts for 73.1% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2024 at $18,794 and has fallen 86.1% since, to $2,610 in 2025. Among physician assistant clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 209 payments — averaging $112.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$17K
- AstraZeneca$1K
- GSK$1K
- Jazz Pharmaceuticals Inc.$944
- Boehringer Ingelheim$471
- Grifols USA, LLC$300
- plus $2K from 20 others
What the payments were for
- Consulting fees$17,22373%
- Food & beverage$6,14426%
- Education$2011%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 2 | $17,223 |
| AstraZeneca | 32 | $1,271 |
| GSK | 44 | $1,049 |
| Jazz Pharmaceuticals Inc. | 16 | $944 |
| Boehringer Ingelheim | 15 | $471 |
| Grifols USA, LLC | 12 | $300 |
| Amgen | 16 | $275 |
| Regeneron Healthcare Solutions, Inc. | 13 | $274 |
| Harmony Biosciences LLC | 3 | $264 |
| Verona Pharma, Inc. | 12 | $261 |
| Sanofi | 10 | $246 |
| Alk-abello, Inc | 6 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $129 |
| Novo Nordisk | 1 | $125 |
| Fisher & Paykel Healthcare Inc | 4 | $104 |
| Insmed, Inc. | 5 | $92 |
| Pulmonx Corporation | 3 | $81 |
| Sanofi-aventis U.S. LLC | 1 | $79 |
| Avadel CNS Pharmaceuticals, LLC | 3 | $47 |
| Mylan Specialty L.p. | 1 | $43 |
| 3b Medical, Inc. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $38 |
| Boston Scientific | 1 | $18 |
| Lilly USA, LLC | 1 | $18 |
| United Therapeutics Corporation | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,568 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 313 | $327,454 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 127 | $102,190 |
| Breo ElliptaFluticasone/Vilanterol | 78 | $41,515 |
| Incruse ElliptaUmeclidinium Bromide | 81 | $35,658 |
| Spiriva RespimatTiotropium Bromide | 39 | $26,387 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 36 | $25,574 |
| XolairOmalizumab | 11 | $25,502 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 84 | $15,042 |
| Advair HfaFluticasone Propion/Salmeterol | 30 | $14,781 |
| Spiriva HandihalerTiotropium Bromide | 18 | $12,789 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 376 | $9,425 |
| SymbicortBudesonide/Formoterol Fumarate | 30 | $8,738 |
| AirsupraAlbuterol Sulfate/Budesonide | 14 | $6,255 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $5,040 |
| Azelastine Hcl | 182 | $3,722 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta, Anoro Ellipta | $1,049 | $430,201508 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Airsupra | $1,271 | $117,183171 claims |
| Boehringer IngelheimSpiriva Respimat | $471 | $26,38739 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Lewistown
- Erin CrownState College$1.2M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Jeffrey CameronWashington$89K
- Dorissa BrivchikPittsburgh$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.